VIP regimen

Jump to navigation Jump to search

WikiDoc Resources for VIP regimen


Most recent articles on VIP regimen

Most cited articles on VIP regimen

Review articles on VIP regimen

Articles on VIP regimen in N Eng J Med, Lancet, BMJ


Powerpoint slides on VIP regimen

Images of VIP regimen

Photos of VIP regimen

Podcasts & MP3s on VIP regimen

Videos on VIP regimen

Evidence Based Medicine

Cochrane Collaboration on VIP regimen

Bandolier on VIP regimen

TRIP on VIP regimen

Clinical Trials

Ongoing Trials on VIP regimen at Clinical

Trial results on VIP regimen

Clinical Trials on VIP regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on VIP regimen

NICE Guidance on VIP regimen


FDA on VIP regimen

CDC on VIP regimen


Books on VIP regimen


VIP regimen in the news

Be alerted to news on VIP regimen

News trends on VIP regimen


Blogs on VIP regimen


Definitions of VIP regimen

Patient Resources / Community

Patient resources on VIP regimen

Discussion groups on VIP regimen

Patient Handouts on VIP regimen

Directions to Hospitals Treating VIP regimen

Risk calculators and risk factors for VIP regimen

Healthcare Provider Resources

Symptoms of VIP regimen

Causes & Risk Factors for VIP regimen

Diagnostic studies for VIP regimen

Treatment of VIP regimen

Continuing Medical Education (CME)

CME Programs on VIP regimen


VIP regimen en Espanol

VIP regimen en Francais


VIP regimen in the Marketplace

Patents on VIP regimen

Experimental / Informatics

List of terms related to VIP regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:Etoposide-Ifosfamide-Cisplatin Regimen; VePesid-Ifosfamide-Platinol Regimen; VIP; VIP Regimen; VP16-Ifosfamide-Platinol Regimen


VIP regimen refers to a regimen consisting of etoposide (vepesid), ifosfamide and cisplatin (platinol) used for the treatment of advanced-stage germ cell gonadal cancers[1] and Thymoma.[2]


VVePesid (etoposide)


PPlatinol (cisplatin)



  1. 1.0 1.1 Nichols CR, Catalano PJ, Crawford ED, Vogelzang NJ, Einhorn LH, Loehrer PJ (1998). "Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study". J Clin Oncol. 16 (4): 1287–93. PMID 9552027.
  2. 2.0 2.1 Loehrer PJ, Jiroutek M, Aisner S, Aisner J, Green M, Thomas CR; et al. (2001). "Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial". Cancer. 91 (11): 2010–5. PMID 11391579.